Casdin Capital, LLC 13D/13G Filings for Relay Therapeutics, Inc. (RLAY)

Casdin Capital, LLC 13D and 13G filings for Relay Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-14
4:20 pm
Purchase		 2023-12-31 13G Relay Therapeutics, Inc.
RLAY		 Casdin Capital, LLC 7,387,943
5.990%		 1,089,369increase
(+17.30%)		 Filing
2023-10-02
4:14 pm
Purchase		 2023-09-21 13G Relay Therapeutics, Inc.
RLAY		 Casdin Capital, LLC 6,298,574
5.160%		 6,298,574increase
(New Position)		 Filing